TechMap Live › By country › China
AI & machine learninghigh impactInsilico Medicine AI-designed drug shows biological age reversal in early trial
· Hong Kong, China · Asia-Pacific · no longer in the live window
A Nature Biotechnology study reports rentosertib, an AI-designed drug by Insilico Medicine, reversed biological aging markers by up to six years in early clinical trial patients.
- Topic
- AI & machine learning
- Location
- Hong Kong, China (22.319°, 114.169°)
- Region
- Asia-Pacific
- Impact
- high
- Reported by
- The Decoder
This page was generated automatically by TechMap Live from a public news report published by The Decoder. Coordinates and impact level are estimates — an event is usually pinned at a company's headquarters or launch site. This is an aggregation of news coverage, not original reporting — read the original report before relying on it.
Technology events in China
- Researchers suppress gas buildup in lithium manganese-rich batteries, retain 92.2% energy after 883 cycles
- China's Supreme People's Court issues guidelines on deepfakes and AI disputes
- Xiaomi launches 13.3-inch Pad 9 Pro Max tablet
- Chinese AI robot performs first-ever heart defect surgery via catheter
- Huawei launches Mate XT 2 Ultimate Design tri-fold phone
- Xiaomi launches 18 Fold wide-format foldable phone
Latest events
- Nightmare Eclipse publishes zero-day vulnerability in Microsoft Defender
- Rheinmetall tests Battlesuite platform for controlling drones from one center
- Tesla resumes Roadster pre-orders with $50,000 deposit
- US Army contracts $10.64M for Ukrainian-made Skyetion Raybird drones
- North Korea-linked hackers infect 30,000 devices via fake coding tests
- Moonshot AI supplies Kimi K3 model to AWS
- NASA awards SpaceX $946 million for three crewed ISS missions
- LG Display unveils first 24.5‑inch OLED panel with 720 Hz refresh